Professional Golfer Max Homa Joins Arcutis’ Free to Be Me Campaign, Urging Individuals with Seborrheic Dermatitis to Tee Up a Conversation with Their Healthcare Provider About Long-Term Treatments

Core Viewpoint - Arcutis Biotherapeutics, Inc. has launched the "Free to Be Me" awareness campaign featuring professional golfer Max Homa to raise awareness about seborrheic dermatitis and encourage patients to seek long-term treatment options [1][2][12] Company Overview - Arcutis Biotherapeutics is a commercial-stage biopharmaceutical company focused on innovations in immuno-dermatology, with a commitment to addressing the needs of individuals with immune-mediated dermatological diseases [16] Product Information - ZORYVE (roflumilast) foam 0.3% is a steroid-free topical treatment for seborrheic dermatitis, effective in reducing itching, redness, and flaking [4][10] - Clinical trials show that 77% of patients using ZORYVE foam achieved clear or almost clear skin after 8 weeks, compared to 53% using an inactive foam [7][8] - The product is indicated for adults and children aged 9 and older, and is designed to be safe and well-tolerated, with common side effects including common cold (1.5%), nausea (1.3%), and headache (1.1%) [9][13] Market Context - Approximately 10 million Americans suffer from seborrheic dermatitis, a chronic inflammatory skin disease that can significantly impact quality of life [4] - ZORYVE foam is recognized as the number one prescribed branded topical therapy for atopic dermatitis, seborrheic dermatitis, and plaque psoriasis [10][11] Campaign Details - The "Free to Be Me" campaign aims to share real experiences of individuals with inflammatory skin conditions to empower them to discuss treatment options with healthcare providers [12]